Assignee
SCANDION ONCOLOGY AS
DK·3 granted patents·5 pending applications·2 citations·filing 2016–2022
Top patents by PatentIndex Score
8 records- 0170US11103481B2Combination treatment of cancerSCANDION ONCOLOGY AS·Filed 2017·Granted Aug 31, 2021·2 cites·31 claims
- 0260US11903927B2Combination treatment of cancerSCANDION ONCOLOGY AS·Filed 2021·Granted Feb 20, 2024·0 cites·19 claims
- 0360US2024374567A1Combination Treatments for Cancer Patients and Methods for Identifying SameSCANDION ONCOLOGY AS·Filed 2022·Application pending·0 cites
- 0460US2024277666A1Combination Treatments for Cancer Patients and Methods for Identifying SameSCANDION ONCOLOGY AS·Filed 2022·Application pending·0 cites
- 0552US2025262188A1Methods of Increasing the Plasma Drug Exposure of Anticancer AgentsSCANDION ONCOLOGY AS·Filed 2022·Application pending·0 cites
- 0646US2021251963A1Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1SCANDION ONCOLOGY AS·Filed 2019·Application pending·0 cites
- 0745US2024360087A1Thermodynamically stable form of sco-101SCANDION ONCOLOGY AS·Filed 2022·Application pending·0 cites
- 0829US10975079B24-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatmentsSCANDION ONCOLOGY AS·Filed 2016·Granted Apr 13, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when SCANDION ONCOLOGY AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →